Can we list where all Nader or management made false statements about the results of their trials?
The only questionable case that comes to my mind is the claim that NEWS2 was SS in cd10. FDA in stating (that's how I read their letter) that cd10 had no SS results seemed to directly contradict the PR that NEWS2 was SS.
I don't recall anywhere else where their statements can be regarded as anything more than forward-looking. With NEWS2, that was a definite mess-up either from management or from FDA. I was upset with the management that they never explained this directly. Either they lied about it to shareholders or were (understandably) afraid to poke the bear any further.
Also anyone know the date of the cc when Nader guaranteed Revenue within a week from Philippines? I want to listen to him again. In my common sense I took that as forward looking right when I heard. Like I do any statement about Brazil trial being very close or "any day now", or likely having first patient soon. We know that it is dependent on other factors coming together beyond the control of management, and till it happens, all such statements must be taken as FLS. Shareholders need to accept what that means and how to sift it from verified written information.
But does that mean they should not point out subgroup analyses that show LL's potential? NO, not for me as a shareholder. Not unless FDA directly makes a rule that defines the limits in no uncertain terms, where we can show Nader's statements as having crossed the boundaries of FLS. Otherwise I certainly want to know all that they can figure out from the data that shows promise. When the trials are low-powered, we have to try and glean the possibilities if the data can show them somehow. Doesn't mean we claim it will come through in a bigger trial. If people think it is all a hoax by Nader and co. to project such info, then they should accept the thesis that LL is just saline and just stay with that. Otherwise of course it matters all that they found and advertised about the subgroup results in cd12, etc. We are in Brazil still not because Nader wants to keep the ball rolling, but because we still believe that past results show great possibility that LL works in Covid.
